About Chemtech Intermediates Limited
Data last updated:
Chemtech Intermediates Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24236GJ1995PLC024448. Its GSTIN is 24AAACC7914Q1ZC (Gujarat).
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹3.49 Cr. It is led by directors including Ripal Natawarlal Patel (Managing Director) and Manisha Ripal Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 712 – 713 Sidharth Complex R C Dutt Road Race Course, Vadodara, Gujarat, India – 390007.
As per the financials filed for FY 2025, the company reported a revenue of ₹109 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹7.64 Cr (net margin 7%) and EBITDA of ₹16.83 Cr (EBITDA margin 15.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
The company has about 36 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: ERPOpel. As per MCA filings, the company has open charges of ₹38.12 Cr and satisfied charges of ₹50.3 Cr on record. The company has 8 deals on record (8 secondary share transfers); the latest was in March 2024. Its 10 peer companies in the Chemicals industry (Aromatics, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Auracare Pharma Private Limited with revenue of ₹111 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 804 overdue payments to 38 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cipl.co.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address712 – 713 Sidharth Complex R C Dutt Road Race Course, Vadodara, Gujarat, India – 390007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Chemtech Intermediates Limited
The main business activity of Chemtech Intermediates is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Chemtech Intermediates Limited FY 2025 filings available
Chemtech Intermediates Limited reported revenue of ₹109 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Chemtech Intermediates Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 33% growth in the latest year. EBITDA rose 131% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Chemtech Intermediates Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.83 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.64 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Chemtech Intermediates Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chemtech Intermediates are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Chemtech Intermediates Limited
Chemtech Intermediates Limited is compared with the companies closest to it by revenue in the Chemicals industry (Aromatics, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auracare Pharma Private Limited | ₹111 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Ahmedabad, Gujarat, India |
| STG Pharmagenerics Private Limited | ₹110.75 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Horizon Bioceuticals Pvt Ltd | ₹110.37 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Panipat, Haryana, India |
| Inventaa Industries Private Limited | ₹109.72 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Kanchikacherla, Andhra Pradesh, India |
| Novus Life Sciences Private Limited | ₹109.09 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | Mumbi, Maharashtra, India |
| Chemtech Intermediates Limited this company | ₹109 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Vadodara, Gujarat, India |
| Quest Laboratories Limited | ₹108.21 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Dhar, Madhya Pradesh, India |
| Meyonex Pharmaceuticals Limited | ₹108.15 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Palghar, Maharashtra, India |
| Sacheerome Limited | ₹108.13 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | New Delhi, Delhi, India |
| Shiva Biogenetic Pharmaceuticals Private Limited | ₹107.81 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Solan, Himachal Pradesh, India |
| Unimed Technologies Limited. | ₹107.74 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Chemtech Intermediates by revenue in the Chemicals industry (Aromatics, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Chemtech Intermediates Limited
Chemtech Intermediates has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ripal Natawarlal Patel | Managing Director | 26 Feb 2015 | 11 Years 7 Months | Current |
| Manisha Ripal Patel Also directs: Chemtech Finechem Private Limited | Director | 26 Feb 2015 | 11 Years 7 Months | Current |
| Shalin Ripalkumar Patel | Director | 21 Jul 2025 | 1 Years 2 Months | Current |
Charges & Borrowings of Chemtech Intermediates Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2025 | Others | ₹3 Cr | Open |
| 30 Nov 2024 | Others | ₹10 Cr | Open |
| 02 Jul 2024 | Others | ₹4.9 Cr | Open |
| 30 Apr 2024 | Others | ₹1.49 Cr | Open |
| 30 Apr 2024 | Others | ₹5.5 Cr | Open |
Total charge records: 13 View all charges
Deals & Funding of Chemtech Intermediates Limited
Chemtech Intermediates Limited has 8 deals on record (8 secondary share transfers); the latest was in March 2024.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Jan 2024 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Panorama Aromatics Limited , an individual |
| Jul 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
Full deal history
All 8 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Chemtech Intermediates Limited
Chemtech Intermediates Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 804 overdue payments to 38 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 38)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Panorama Aromatics Ltd. | •••• | •••• | •••• |
| Giriraj Gases | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Shiv Pumps Private Limited | •••• | •••• | •••• |
| Kadillac Chemicals Pvt Ltd | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Chemtech Intermediates Limited
Chemtech Intermediates operates one associated brand: ERPOpel. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides SaaS-based ERP solutions tailored for educational institutions. | odcipl.com |
Employees and EPFO Compliance at Chemtech Intermediates Limited
Employment history and EPFO contributions of people linked to Chemtech Intermediates.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Chemtech Intermediates Limited
Chemtech Intermediates has one previous CIN (Corporate Identification Number): U24236GJ1995PTC024448. The current CIN is U24236GJ1995PLC024448, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24236GJ1995PLC024448 | Current |
| U24236GJ1995PTC024448 | Previous |
Recent Activity on Chemtech Intermediates Limited
Chemtech Intermediates Limited has 7 board changes on record since 2015: 3 appointments and 4 cessations. The latest: Shalin Ripalkumar Patel ceased to be Additional Director on 29 Sep 2025.
26 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Chemtech Intermediates Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Chemtech Intermediates Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Chemtech Intermediates Limited
Chemtech Intermediates has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACC7914Q1ZC | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Chemtech Intermediates Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemtech Intermediates Limited
Chemtech Intermediates is an active public limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 February 1995 (31+ years old) and is registered under CIN U24236GJ1995PLC024448.
Chemtech Intermediates reported revenue of ₹109 Cr for FY 2025 (up 33% YoY).
Chemtech Intermediates has 3 current directors:
- Ripal Natawarlal Patel - Managing Director
- Manisha Ripal Patel - Director
- Shalin Ripalkumar Patel - Director
Chemtech Intermediates reported a net profit of ₹7.64 Cr (net margin 7%) and EBITDA of ₹16.83 Cr (EBITDA margin 15.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Chemtech Intermediates is 18% over three years and 12% over five years. In the latest year (FY 2025) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Chemtech Intermediates is 24AAACC7914Q1ZC, registered in Gujarat.
The CIN (Corporate Identification Number) of Chemtech Intermediates is U24236GJ1995PLC024448. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemtech Intermediates was incorporated on 01 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Chemtech Intermediates has 8 deals on record (8 secondary share transfers); the latest was in March 2024.
The peers of Chemtech Intermediates by revenue are Auracare Pharma Private Limited, STG Pharmagenerics Private Limited, Horizon Bioceuticals Pvt Ltd, Inventaa Industries Private Limited, Novus Life Sciences Private Limited and 5 more, all in the Chemicals industry (Aromatics, Formulations).
Shalin Ripalkumar Patel ceased to be Additional Director on 29 Sep 2025. Shalin Ripalkumar Patel was appointed as Director on 21 Jul 2025. Ranjitsingh Shivaji Vaghela ceased to be Director on 01 Dec 2015. Chemtech Intermediates has 7 board changes on record in total.
Chemtech Intermediates has 14 MSME Form 1 returns on record between 2019 and 2024, listing 804 overdue payments to 38 micro and small suppliers. The latest return was filed on 15 Dec 2023.